Clinical trial · Observational
Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008
Thromboembolic Complications Related to Asparaginase in Children With ALL Treated According to NOPHO ALL 2008
NCT00982514CI-TRIAL-00008013unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study will examine the prevalence of venous thromboembolism in children with acute lymphoblastic leukaemia treated in accordance with NOPHO ALL-2008. The investigators will prospectively study clinical symptomatic thromboses, asymptomatic central line-associated thromboses, and infections.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia | ONTOLOGY_EXACT | 0.98 |
| Thromboembolism | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Standard dose asparaginase
- description
- Children who according to the protocol NOPHO ALL 2008 receive standard dose asparaginase
- label
- Reduced dose asparaginase
- description
- Children who receive reduced dose asparaginase according to NOPHO ALL 2008
Primary outcomes (2)
- measure
- Clinical evident thrombosis
- timeFrame
- 33 weeks
- measure
- Asymptomatic central line-associated thrombosis
- timeFrame
- 33 weeks
Secondary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Year
- Maximum age
- 16 Years
Show eligibility criteria text
Inclusion Criteria: * Acute lymphoblastic leukaemia, * Age 1 year to 16 years old, * Central line, * Protocol NOPHO ALL 2008. Exclusion Criteria: * Refusal of participation, * Treated according to protocol other than NOPHO ALL 2008.
References
Publications (0)
Data not yet available
No reference posted for this study.